Results 41 to 50 of about 2,421 (106)

Les soins palliatifs en hématologie: quel avenir en Afrique? [PDF]

The Pan African Medical Journal, 2011
Les hémopathies malignes sont des maladies graves qui touchent de nombreux individus à travers le monde. Elles marquent l’entrée dans un lourd et long processus de soins. Le continent africain n’en est pas épargné. La lutte contre ce fléau en Afrique est
Illias Tazi, Hatim Nafil, Lahoucine Mahmal   +2 more
doaj  

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

Arthritis &Rheumatology, Volume 78, Issue 2, Page 475-482, February 2026.
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar, Dafne Capelusnik, Corrado Campochiaro, Valentin Lacombe, Vincent Jachiet, Michael Zisapel, Iftach Sagy, Oshrat E. Tayer‐Shifman, David Ozeri, Shaye Kivity, Alessandro Tomelleri, Benjamin Terrier, Hagit Peleg, Thibault Comont, Karim Sacre, Pascal Woaye‐Hune, Laurent Arnaud, Estibaliz Lazaro, Vincent Grobost, Francois Lifermann, Maxime Samson, Samuel Ardois, Alice Garnier, Alexandre Maria, Alain Cantagrel, Aurore Meyer, Jean‐David Bouaziz, Mael Heiblig, Lorenzo Dagna, Elisa Diral, Olivier Kosmider, Ori Elkayam, Jérôme Hadjadj, Sophie Georgin‐Lavialle, Olivier Fain, Arsene Mekinian   +35 more
wiley   +1 more source

Breast cancer at Hôpital Principal De Dakar. A descriptive study of 46 cases. [PDF]

Batna Journal of Medical Sciences
Introduction. Breast cancer is a public health problem. It is the second most common cancer in Senegal after cervical cancer according to Gobocan 2020.
Ndèye Marième DIAGNE, Marie Monique TINE, Elimane Seydi BOUSSO, Mame Diarra NDAW, Rokhaya NIASSE, Biram NDIAYE, Ibrahima SALL   +6 more
doaj   +1 more source

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium

British Journal of Haematology, Volume 208, Issue 1, Page 250-258, January 2026.
The overall survival of patients receiving an allogeneic haematopoietic stem cell transplant (HSCT) for GATA2 deficiency was significantly better if they were transplanted recently, with a bone marrow or cord blood graft and if the transplant was performed before the onset of excess blast. Excess blast before HSCT was the only factor associated with an
Flore Sicre de Fontbrune, Florian Chevillon, Mony Fahd, Kristell Desseaux, Xavier Poiré, Edouard Forcade, Arthur Sterin, Bénédicte Neven, Virginie Gandemer, Sylvain Thepot, Alice Garnier, Bruno Lioure, Ambroise Marcais, Stephanie Nguyen‐Quoc, Suzanne Tavitian, Laure Vincent, Jean Donadieu, Matthieu Resche Riggon, Sylvie Chevret, Marlene Pasquet, Regis Peffault de Latour   +20 more
wiley   +1 more source

Real‐life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study

eJHaem
The real‐life retrospective observational study CARMYN aimed at investigating the long‐term efficacy and safety of carfilzomib in combination with dexamethasone and lenalidomide (KRd, 159 patients). These patients (62% in first and 38% in second relapse,
Kamel Laribi, Xavier Leleu, Nathalie Texier, Raphaël Germain, Cyrille Touzeau, Mohammad Hammoud, Alexandre Payssot, Samantha Schulmann, Ronan Le Calloch, Adrien Trebouet, Driss Chaoui, Selva David, Omar Benbrahim, Riad Benramdane, Anne Charvet‐Rumpler, Christelle Jadeau, Eglantine Rouanet, Olivier Decaux, Aurore Perrot   +18 more
doaj   +1 more source

Massive circulating metastatic cells: A case of carcinocythemia

Clinical Case Reports
Key Clinical Message Importance of careful differential diagnosis to make the distinction between carcinocythemia and acute leukemia or lymphoma.
Carine Farkh, Jérome Debus, Valérie Andrieu, Juliette Gay   +3 more
doaj   +1 more source

Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy

Haematologica, 2018
Evading immune eradication is a prerequisite for neoplastic progression and one of the hallmarks of cancer. Here, we review the different immune escape strategies of lymphoma and classify them into two main mechanisms. First, lymphoma cells may “hide” to
Marie de Charette, Roch Houot
doaj   +1 more source

Distinct Tryptase Gene Copy Number Variations Correlate With Tryptase Levels in a Population‐Based Cohort

Allergy, Volume 81, Issue 4, Page 1277-1280, April 2026.
Yannick Chantran, Simone Choi, Céline Roda, Stéphane Barete, Pierre Hirsch, Olivier Hermine, Laura Polivka, Julien Rossignol, Michel Arock, Fanny Rancière, Isabelle Momas   +10 more
wiley   +1 more source

P-085: THE MORBIDITY AND MORTALITY OF SICKLE CELL DISEASE PATIENTS IN THE HAEMATOLOGY DEPARTMENT OF THE IGNACE DEEN HOSPITAL, CONAKRY HOSPITAL AND UNIVERSITY CENTRE

HemaSphere, 2022
DIAKITE M., GUILAVOGUI F., KANTE A., CONDE A., SYLLA M., TOUNKARA T.   +5 more
doaj   +1 more source

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

Haematologica, 2018
The purpose of this study was to identify the incidence, causes and impact of non-adherence to oral and subcutaneous chronic treatments for patients with polycythemia vera or essential thrombocythemia.
Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, Adrian Tempescul, Florence Dalbies, Jean-Richard Eveillard, Valérie Ugo, Stéphane Giraudier, Gaëlle Guillerm, Eric Lippert, Christian Berthou, Jean-Christophe Ianotto   +13 more
doaj   +1 more source